Literature DB >> 32651166

Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated Macrophages.

Ilaria Marigo1, Rosalinda Trovato2, Francesca Hofer3, Vincenzo Ingangi4, Giacomo Desantis4, Kevin Leone4, Francesco De Sanctis3, Stefano Ugel3, Stefania Canè3, Anna Simonelli3, Alessia Lamolinara5, Manuela Iezzi5, Matteo Fassan6, Massimo Rugge6, Federico Boschi7, Giulia Borile8,9, Thomas Eisenhaure10, Siranush Sarkizova10, David Lieb10, Nir Hacohen10, Luca Azzolin11, Stefano Piccolo11,12, Rita Lawlor13, Aldo Scarpa13,14, Luisa Carbognin15, Emilio Bria15, Silvio Bicciato16, Peter J Murray17, Vincenzo Bronte2.   

Abstract

Tumor-associated macrophages (TAM) are regulators of extracellular matrix (ECM) remodeling and metastatic progression, the main cause of cancer-associated death. We found that disabled homolog 2 mitogen-responsive phosphoprotein (DAB2) is highly expressed in tumor-infiltrating TAMs and that its genetic ablation significantly impairs lung metastasis formation. DAB2-expressing TAMs, mainly localized along the tumor-invasive front, participate in integrin recycling, ECM remodeling, and directional migration in a tridimensional matrix. DAB2+ macrophages escort the invasive dissemination of cancer cells by a mechanosensing pathway requiring the transcription factor YAP. In human lobular breast and gastric carcinomas, DAB2+ TAMs correlated with a poor clinical outcome, identifying DAB2 as potential prognostic biomarker for stratification of patients with cancer. DAB2 is therefore central for the prometastatic activity of TAMs. SIGNIFICANCE: DAB2 expression in macrophages is essential for metastasis formation but not primary tumor growth. Mechanosensing cues, activating the complex YAP-TAZ, regulate DAB2 in macrophages, which in turn controls integrin recycling and ECM remodeling in 3-D tissue matrix. The presence of DAB2+ TAMs in patients with cancer correlates with worse prognosis.This article is highlighted in the In This Issue feature, p. 1611. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32651166     DOI: 10.1158/2159-8290.CD-20-0036

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  12 in total

Review 1.  Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies.

Authors:  Simone Caligola; Francesco De Sanctis; Stefania Canè; Stefano Ugel
Journal:  Front Genet       Date:  2022-05-16       Impact factor: 4.772

2.  Identifying Dendritic Cell-Related Genes Through a Co-Expression Network to Construct a 12-Gene Risk-Scoring Model for Predicting Hepatocellular Carcinoma Prognosis.

Authors:  Chaoyuan Huang; Xiaotao Jiang; Yuancheng Huang; Lina Zhao; Peiwu Li; Fengbin Liu
Journal:  Front Mol Biosci       Date:  2021-05-24

3.  Activation of the adipocyte CREB/CRTC pathway in obesity.

Authors:  Young-Sil Yoon; Weiyi Liu; Sam Van de Velde; Shigenobu Matsumura; Ezra Wiater; Ling Huang; Marc Montminy
Journal:  Commun Biol       Date:  2021-10-22

Review 4.  A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment.

Authors:  Francesca Hofer; Gianna Di Sario; Chiara Musiu; Silvia Sartoris; Francesco De Sanctis; Stefano Ugel
Journal:  Cells       Date:  2021-10-09       Impact factor: 6.600

5.  CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy.

Authors:  Arne Billmeier; Krutika Khinvasara; Franziska Lang; Julia Mohr; Daniel Reidenbach; Maik Schork; Ikra Yildiz; Mustafa Diken
Journal:  Hum Vaccin Immunother       Date:  2022-02-07       Impact factor: 3.452

Review 6.  The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.

Authors:  Huogang Wang; Mingo M H Yung; Hextan Y S Ngan; Karen K L Chan; David W Chan
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

Review 7.  The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies.

Authors:  Giovanni Zarrilli; Gianluca Businello; Maria Vittoria Dieci; Silvia Paccagnella; Valentina Carraro; Rocco Cappellesso; Federica Miglietta; Gaia Griguolo; Valentina Guarneri; Marcello Lo Mele; Matteo Fassan
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

Review 8.  Emerging Roles of Disabled Homolog 2 (DAB2) in Immune Regulation.

Authors:  Vanessa Figliuolo da Paz; Fayez K Ghishan; Pawel R Kiela
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

Review 9.  Label-Free Multiphoton Microscopy: Much More Than Fancy Images.

Authors:  Giulia Borile; Deborah Sandrin; Andrea Filippi; Kurt I Anderson; Filippo Romanato
Journal:  Int J Mol Sci       Date:  2021-03-06       Impact factor: 5.923

10.  Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.

Authors:  Weiyu Dai; Yizhi Xiao; Weimei Tang; Jiaying Li; Linjie Hong; Jieming Zhang; Miaomiao Pei; Jianjiao Lin; Side Liu; Xiaosheng Wu; Li Xiang; Jide Wang
Journal:  Front Genet       Date:  2021-06-24       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.